CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The CHAPAS-5 trial aims to evaluate new treatment regimens for children living with HIV in sub-Saharan Africa. It employs a personalized approach to optimize antiretroviral therapy for both treatment-naïve and experienced children, focusing on improving health outcomes and system capacity.
The 2.5 million children and adolescents living with HIV (CALHIV), most residing in sub-Saharan Africa, have unacceptably high rates of late diagnosis, treatment failure and death, compared to their adult counterparts. CALHIV are a vulnerable group who have been left behind adults in testing new treatment options, different modes of ART delivery, novel diagnostics and adherence strategies.
The CHAPAS-5 trial is a sustainable multi-country adaptive platform trial in Mozambique, Uganda and Zimbabw…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
JOINT CLINICAL RESEARCH CENTRE
Uganda, KAMPALA
Type: Research institute
Activity type: Research Organisations
SME: No
Zimbabwe, Harare
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Mozambique, Maputo
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
CENTRE FOR SEXUAL HEALTH AND HIV AND AIDS RESEARCH
Zimbabwe, HARARE
Type: Research institute
Activity type: Research Organisations
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
